Dow Down 1.40% Nasdaq Down 1.59%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.04 0.22(5.16%) Oct 1, 4:00PM EDT
Prev Close:4.26
Open:4.26
Bid:4.05 x 1000
Ask:4.10 x 500
1y Target Est:11.00
Beta:1.61
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.01 - 4.27
52wk Range:4.01 - 7.82
Volume:4,772,445
Avg Vol (3m):3,801,270
Market Cap:495.04M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 5.16%495.04M
ABT61.92B
GSK110.25B
RHHBY249.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):152.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback